New Arrivals/Restock

RAS Signaling Pathway in Cancer Therapy, (Hardcover)

flash sale iconLimited Time Sale
Until the end
16
17
39

US$50.23 cheaper than the new price!!

Free shipping for purchases over $99 ( Details )
Free cash-on-delivery fees for purchases over $99
Please note that the sales price and tax displayed may differ between online and in-store. Also, the product may be out of stock in-store.
Used  US$33.48
quantity

Product details

Management number 238674965 Release Date 2026/07/11 List Price US$33.48 Model Number 238674965
Category

<p>The RAS signaling pathway represents one of the most significant and challenging targets in oncology. Mutations in RAS genes are identified in approximately one quarter of all human malignancies, driving processes such as tumor initiation and maintenance. For decades, RAS proteins were considered undruggable, but persistent research led to a major breakthrough in 2021 with the approval of the first inhibitor targeting a specific mutant isoform of KRAS (KRASG12C), followed by the development of other RAS inhibitors targeting specific isoforms or multiple mutations at the same time. This Reprint provides a collection of original articles and reviews focusing on different aspects of RAS signaling. It explores the diverse roles of RAS signaling across various cellular contexts and identifies potential vulnerabilities that could expand treatment options for patients. By integrating genetic studies and biochemical analyses, the included works offer insights into novel therapeutic strategies designed to overcome both intrinsic and acquired resistance. A primary goal of the research presented here is to refine the understanding of these pathways to develop more effective treatments while minimizing therapy-related toxicities. As the field moves toward a more personalized approach to cancer care, understanding the intricate requirements for RAS signaling is more critical than ever. This collection serves as a valuable resource for researchers and clinicians dedicated to advancing the state of cancer therapy and improving patient outcomes through a deeper knowledge of molecular pathogenesis and targeted interventions.</p>

  • RAS Signaling Pathway in Cancer Therapy, (Hardcover)
  • Author: Mdpi AG
  • ISBN: 9783725869428
  • Format: Hardcover
  • Publication Date: 2026-03-09
  • Page Count: 156
Book format Hardcover
Fiction/nonfiction Non-Fiction
Genre Textbooks
Publication date March, 2026
Pages 156
Subgenre Life Sciences
Series title No Series
Number in series 0
Edition 1
Publisher Mdpi AG
Language English
Is collectible N
Binding type Case Binding
Recording time 0 min
Retail packaging Single Piece
Assembled product dimensions (l x w x h) 6.69 x 0.56 x 9.61 in
Assembled product weight 1.19 lb
Bisac subject heading Science

Correction of product information

If you notice any omissions or errors in the product information on this page, please use the correction request form below.

Correction Request Form

Product Review

You must be logged in to post a review